1-{[(10R,13S,16S,19S,22R)-13-(2-amino-2-oxoethyl)-19,22-dibenzyl-16-(1-methylethyl)-12,15,18,21,24-pentaoxo-7,8-dithia-11,14,17,20,23-pentaazaspiro[5.19]pentacos-10-yl]carbonyl}-L-prolyl-N~5~-(diaminomethylidene)-L-ornithylglycinamide,81094-03-3 Products Supply

Name: 1-{[(10R,13S,16S,19S,22R)-13-(2-amino-2-oxoethyl)-19,22-dibenzyl-16-(1-methylethyl)-12,15,18,21,24-pentaoxo-7,8-dithia-11,14,17,20,23-pentaazaspiro[5.19]pentacos-10-yl]carbonyl}-L-prolyl-N~5~-(diaminomethylidene)-L-ornithylglycinamide
CAS NO.: 81094-03-3
Synonyms:
AC1MJ5MG;d(CH2)5(D-Phe(2))vavp;Skf 101071;SKF-101071;Argipressin, (2-mercapto-beta,beta-cyclopentamethylenepropionic acid)(1)-phe(2)-val(4)-;(2S)-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-1-[(10R,13S,16S,19S,22R)-19-(2-amino-2-oxoethyl)-10,13-dibenzyl-8,11,14,17,20-pentaoxo-16-propan-2-yl-24,25-dithia-9,12,15,18,21-pentazaspiro[5.19]pentacosane-22-carbonyl]pyrrolidine-2-carboxamide;1-(2-Mercapto-beta,beta-cyclopentamethylenepropionic acid)-2-phenylalanyl-4-valine-argipressin;81094-03-3;Arginine vasopressin, (2-mercapto-beta,beta-cyclopentamethylenepropionic acid)(1)-phe(2)-val(4)-;Vasopressin, 1-(1-mercaptocyclohexaneacetic acid)-2-D-phenylalanine-4-L-valine-8-L-arginine-
Molecular Structure:
Molecular Formula: C₅₁H₇₃N₁₃O₁₀S₂

Send a message direct to supplier(s)*

Please post your buying leads,so that our qualified suppliers will soon contact you!

CAS NO.：
* Purchase Request：

* Your Email：
* Name：
* Gender：	Male Female
* Country/Area：
* Company Name：
* Tel：	- - Country - Code Area - Code Number

* Message：

Related products: 1-{[(10R,13S,16S,19S,22R)-13-(; 1/C26H18O2/c1-17-16-23-21-9-5-; 1/C22H28O6/c1-23-17-11-21(27-5; 1/C19H15ClN2O2S/c1-11-19(23)24; 1/C21H26N2O4/c1-3-14-8-9-19(25; 1/C19H20O5/c1-11(2)7-18(21)24-; 1/C18H18O6/c1-22-14-8-13(20)15; 1/C17H22N6/c1-2-8-19-13-11-14(; 1/C18H19NO4/c1-22-15-8-11-10(7; 1/C19H24N2O2/c1-12(2)14-8-6-9-; 1/C23H22N2O2/c26-23(27-22-15-2; 1/C27H27N3O3S/c1-30-25(20-11-1; 1/C17H16N2O3/c1-9(20)12-8-14-1; 1/C20H20N2/c1-4-10-16(11-5-1)1; 1-{[7-(2-amino-2-oxoethyl)-10-; 1/C18H30O4/c1-4-5-6-7-15(19)13; 1/C14H13N7O/c1-8-12(21-14(17)1; 1/C33H42O7/c1-19-25-17-24-18-2; 1-{[(4R,7S,10S,13S,16S)-7-(2-a; 1-{[11-(2-amino-2-oxoethyl)-8-; 1-({(4R,7S,13S,16S)-7-(2-amino; 1/C16H15FN2O3S/c1-23(21,22)19-; 1-{[(4R,7S,10S,16S,19R)-19-ami; 1-{[(4R,7S,10S,16S,19R)-19-ami; 1-{[(4R,7S,10S,16S,19R)-19-ami; 1/C16H14ClNO3/c1-10-6-12(17)7-; 1-{[(4R,7S,10S,16S,19R)-19-ami; 1-{[(4R,7S,10S,13R,16S,19R)-19; Spiro[cyclohexane-1,2'-[9,4](e; 1/C30H52/c1-10-25(6)16-12-20-3;